Inhibikase Therapeutics Inc. PS Ratio 2020–2026

PE Ratio PS Ratio Price to Book Price to FCF Net Worth

Current and historical P/S ratio for Inhibikase Therapeutics Inc. (IKT): market cap divided by trailing twelve-month revenue. As of September 30, 2024 it is 145.12.

From: 03/31/2021To: 03/31/2026

Stock Price

TTM Revenue

PS Ratio

Inhibikase Therapeutics Inc. PS Ratio — FAQ

Inhibikase Therapeutics Inc. (IKT) ps ratio over the last 5 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see IKT's ps ratio history?

The chart and table above show Inhibikase Therapeutics Inc.'s ps ratio by year and by quarter, including the growth rate.